© 2022 BioMarin. All rights reserved.

Founded in 1997, BioMarin Pharmaceutical Inc. (“BioMarin” or the “Company”) develops and commercialises innovative biopharmaceuticals for serious diseases and medical conditions, focusing on product candidates that address currently unmet medical needs, suggest a clear-cut development profile and provide an opportunity to be first-to-market. It is our policy to conduct all aspects of our business in accordance with the highest standards of ethical behaviour. In furtherance of this policy, we are committed to compliance with the laws and regulations applicable to our business.

BioMarin’s Global Compliance & Ethics Program (the “Program”) is an enterprise-wide global initiative that addresses the seven elements discussed in the OIG Compliance Program Guidance for Pharmaceutical Manufacturers, as well as the tenets of the U.S. Federal Sentencing Guidelines, and other applicable laws and regulations. The purpose of the Program is to prevent, detect and correct fraud, misconduct, and violations of company policies, procedures, and/or applicable laws and regulations. The Program applies to BioMarin Directors, officers, employees and, in certain situations, our agents, consultants, and independent contractors.


The Corporate Governance & Nominating Committee and Audit Committee of the BioMarin Board of Directors has ultimate authority to oversee the Program and Chief Compliance Officer (the “Compliance Officer”). The intent of the Board and Company officers is to set the tone for the ethical behaviour expected of all Directors, officers, employees, and business partners.

The Compliance Officer has primary responsibility for strategic program planning related to the Program including ensuring that the Program’s training, policies and procedures, communications, auditing and monitoring, and corrective action processes are developed, in place, and modified as needed. The Compliance Officer reports to the Chief Executive Officer and to the BioMarin Board of Directors.

Policies and Procedures

BioMarin’s Global Code of Conduct & Business Ethics (the “Code”) and the various compliance policies, procedures, and/or processes are integrated across the organisation with department specific procedures or guidance as needed. Among other things, our policies and procedures address the EFPIA Code and other applicable standards and requirements which apply to our EMEA business operations. BioMarin Directors, officers, and employees are expected to comply with all of BioMarin’s global compliance policies, procedures, and processes.

Education and Training

Education is a key element of our Program. Upon hire, all employees receive corporate compliance training on the Code. specialised training occurs in specific departments and across the Company for issues where compliance risks might be greater or where a need for additional training has been identified. The specialised training may include, but is not limited to, modules related to: GDPR, the prohibition of off-label promotion, and healthcare compliance generally. In addition, the trainers and sales managers periodically address corporate compliance issues at regional and national sales meetings. Training is updated as needed for reasons that may include: changes in the law, new risk areas, and changes to our company policies or other regionally specific codes or laws.

Our Program includes education and training of our Directors, officers, and employees on BioMarin’s Program and compliance related activities, risks, and laws.


BioMarin is committed to maintaining the awareness of the Program through communication to its employees. BioMarin distributes communications to employees through a variety of methods including but not limited to the following: all-hands meetings, broadcast emails, and letters. BioMarin also maintains a toll-free hotline for reporting of compliance concerns and a process for investigating and documenting concerns. Access numbers for global locations are available on www.BIOMARIN.ethicspoint.com.

BioMarin encourages Directors, officers, and employees to promptly report suspected or actual violations of our Program and laws and regulations governing our business. Our toll-free hotline allows for anonymous reporting (except where prohibited by law) and is monitored by the Compliance Officer.

Auditing and Monitoring

As part of the Program, BioMarin will conduct auditing and monitoring activities designed to assess compliance with the Program policies, procedures, and processes, identify potential training needs and identify policy, procedure, or process needs.


BioMarin is committed to an effective compliance program. Enforcement action for compliance program violations is addressed in the Code and various human resources policies.

Responding to Detected Offenses

The Program includes the investigation and response to identified or reported compliance issues. The response and level of investigation depends upon the reported or detected issue. The Compliance Officer oversees the investigation and any resulting corrective action that is determined necessary. Corrective action may range from taking appropriate disciplinary action, modifying policies, procedures or processes, employee education, or other action designed to prevent future violations.

BioMarin is committed to compliance and strives to maintain an active and effective Program.

Image: lab techs working in lab
Diversity, Equity & Inclusion

We value diverse perspectives from a broad spectrum of backgrounds, education, personalities, skill sets, experiences, and knowledge.

Learn More about Diversity, Equity & Inclusion at BioMarin